Refractory adult Coats disease treated with dexamethasone intravitreal implant: A case report
| Autor: | Xiaogui Zhao, Gang Liu, Xiu-Ying Wang, Bangtao Yao, Hao Yu, Yuhua Ding |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male exudative retinal detachment medicine.medical_specialty Visual acuity visual acuity Coats disease Dexamethasone 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Recurrence Ophthalmology medicine Dexamethasone Intravitreal Implant Humans 030212 general & internal medicine Coats' disease Clinical Case Report Macular edema Glucocorticoids macular edema business.industry dexamethasone intravitreal implant Retinal General Medicine Exudative retinal detachment Middle Aged medicine.disease eye diseases chemistry 030220 oncology & carcinogenesis Intravitreal Injections Retinal Telangiectasis Female Implant medicine.symptom business medicine.drug Research Article |
| Zdroj: | Medicine |
| ISSN: | 1536-5964 |
| Popis: | Introduction: Coats disease is a sporadic, retinal vascular abnormality, causing blindness. Several interventional methods, including laser photocoagulation, have been proposed; however, the use of intravitreal dexamethasone in refractory Coats disease is not well described. Patient concerns: A 38-year-old man presented with a painless reduction in visual acuity in his right eye, commencing 15 days prior to initial assessment. Diagnosis: Clinical manifestations and multimodal imaging indicated Coats disease. Interventions: Retinal laser photocoagulation was performed in the nonperfused areas, 15 months later, the exudative retinal detachment, and macular edema remained, the patient was then treated with an intravitreal slow-release dexamethasone implant. Outcomes: The exudative retinal detachment and macular edema had resolved, and the BCVA had also improved. Conclusion: Dexamethasone intravitreal implantation was effective in treating refractory Coats disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|